Molecular Biology Reports

, Volume 39, Issue 9, pp 8919–8924 | Cite as

The investigation of allele and genotype frequencies of human C3 (rs2230199) in south Iranian population

  • Najmeh Bazyar
  • Negar Azarpira
  • Saied Reza Khatami
  • Hamid Galehdari


The complement system is an important mediator of natural and acquired immunity. The complement system genes coding complement proteins have polymorphisms. Hereditary deficiencies of this system predispose to autoimmune conditions such as age-dependent macular degeneration or impairment of immunity against microorganisms. When different populations are compared, the frequency of complement polymorphism shows a very marked geographical distribution. The frequency of the functional polymorphism rs2230199 (Arg80Gly; C > G) in the C3 gene was determined in population from south of Iran (n = 200), using polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP). One hundred thirty-eight persons (69 %) were homozygous for C allele (CC or SS); fifty-six person (28 %) heterozygote GC (FS) and six people were homozygous for G allele (GG or FF) (3 %). The allele frequency was 82 % for C3S and 18 % for C3F. A distribution of C3C allele frequency in our population is different from the reports of Asians (100 %); Indians (90–98 %); African-American (93 %); Africans (99 %) and south Brazilian (97 %). However, this finding is similar with the findings Caucasian (80–82 %) (; Americans (80 %); Pushtoon, Hazaras, Osbek and Tajik ethnic groups in Afghanistan (88–90 %) and Tunisian population (84 %). Our study confirmed significant inter-ethnic differences in C3 (rs2230199) frequencies between south Iranians and other ethnic groups. The analysis of genetic variation in complement genes is a tool to provide new insights into the evolution of the human immune system.


C3 gene Polymorphism South Iranian 


  1. 1.
    Reis ES, Falcão DA, Isaac L (2006) Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol 63(3):155–168CrossRefGoogle Scholar
  2. 2.
    Wieme RJ, Demeulenaere L (1967) Genetically determined electrophoretic variant of the human complement component C-prime-3. Nature 214(5092):1042–1043CrossRefPubMedGoogle Scholar
  3. 3.
    Azen EA, Smithies O (1968) Genetic polymorphism of C-prime-3 (beta-1C-globulin) in human serum. Science 162(856):905–907CrossRefPubMedGoogle Scholar
  4. 4.
    Alper CA, Propp RP (1968) Genetic polymorphism of the third component of human complement (C′3). J Clin Invest 47(9):2181–2191CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Botto M, Fong KY, So AK, Koch C, Walport MJ (1990) Molecular basis of polymorphisms of human complement component C3. J Exp Med 172(4):1011–1017CrossRefPubMedGoogle Scholar
  6. 6.
  7. 7.
    Rambausek M, van den Wall Bake AW, Schumacher-Ach R, Spitzenberg R, Rother U, van Es LA, Ritz E (1987) Genetic polymorphism of C3 and Bf in IgA. Nephrol Dial Transpl 2(4):208–211Google Scholar
  8. 8.
    Finn JE, Zhang L, Agrawal S, Jayne DR, Oliveira DB, Mathieson PW (1994) Molecular analysis of C3 allotypes in patients with systemic vasculitis. Nephrol Dial Transpl 9(11):1564–1567Google Scholar
  9. 9.
    Brown KM, Kondeatis E, Vaughan RW, Kon SP, Farmer CK, Taylor JD, He X, Johnston A, Horsfield C, Janssen BJ, Gros P, Zhou W, Sacks SH, Sheerin NS (2006) Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med 354(19):2014–2023CrossRefPubMedGoogle Scholar
  10. 10.
    Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, Clayton DG, Hayward C, Morgan J, Wright AF, Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC (2007) Genetic factors in AMD study group. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357(6):553–561CrossRefPubMedGoogle Scholar
  11. 11.
    Despriet DD, van Duijn CM, Oostra BA, Uitterlinden AG, Hofman A, Wright AF, ten Brink JB, Bakker A, de Jong PT, Vingerling JR, Bergen AA, Klaver CC (2009) Complement component C3 and risk of age-related macular degeneration. Ophthalmology 116(3):474–480CrossRefPubMedGoogle Scholar
  12. 12.
    Spencer KL, Olson LM, Anderson BM, Schnetz-Boutaud N, Scott WK, Gallins P, Agarwal A, Postel EA, Pericak-Vance MA, Haines JL (2008) C3 R102G polymorphism increases risk of age-related macular degeneration. Hum Mol Genet 17(12):1821–1824CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Guerra LK, Rehfeldt IR, Lima MT, Petzl-Erler ML, de Messias IJ (1992) BF and C3 genetic polymorphisms in Kaingang Indians from Southern Brazil. Hum Hered 42(3):153–156CrossRefPubMedGoogle Scholar
  14. 14.
    Raj BK, Shankar V, Damodaran C, Sekharan PC (1988) C3 polymorphism in Kotas and Badagas of Nilgiri Hills, south India. Gene Geogr 2(1):23–26PubMedGoogle Scholar
  15. 15.
    Welch TR, Berry A (1987) C3 alleles in diseases associated with C3 activation. Dis Markers 5(2):81–87PubMedGoogle Scholar
  16. 16.
    Gruppioni G, Lunesu M, Succa V, Vona G (1988) Gc and C3 polymorphisms in Central Sardinia. Hum Hered 38(3):178–179CrossRefPubMedGoogle Scholar
  17. 17.
    Crestani C, Caenazzo L, Cortivo P, Scorretti C, Caenazzo C (1989) Genetic polymorphism of C3 in the Veneto population, Italy. Anthropol Anz 47(4):299–303PubMedGoogle Scholar
  18. 18.
    Agarwal DP, Goedde HW, Benkmann HG, Flatz G, Rahimi AG, Kaifie S, Delbrúck H (1976) Genetic polymorphism of C3 and serum levels of immunoglobulins, C3, C4 component of complement and C3-proactivator in four different population of Afghanistan. Hum Genet 33(1):67–72CrossRefPubMedGoogle Scholar
  19. 19.
    Leban N, Haj Khelil A, Daimi H, Daimi S, Slimene (2007) C3 complement polymorphism in patients suffering from obstructive chronic bronchopneumopathy in Tunisia. Ann Biol Clin (Paris) 65(3):251–256Google Scholar
  20. 20.
    Stringer CB, Andrews P (1988) Genetic and fossil evidence for the origin of modern humans. Science 239(4845):1263–1268CrossRefPubMedGoogle Scholar
  21. 21.
    Laval G, Patin E, Barreiro LB, Quintana-Murci L (2010) Formulating a historical and demographic model of recent human evolution based on resequencing data from noncoding regions. PLoS One 5(4):e10284CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Wall JD, Lohmueller KE, Plagnol V (2009) Detecting ancient admixture and estimating demographic parameters in multiple human populations. Mol Biol Evol 26(8):1823–1827CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Ermini L, Wilson IJ, Goodship TH, Sheerin NS (2012) Complement polymorphisms: geographical distribution and relevance to disease. Immunobiology 217(2):265–271Google Scholar
  24. 24.
    Blekhman R, Man O, Herrmann L, Boyko AR, Indap A, Kosiol C, Bustamante CD, Teshima KM, Przeworski M (2008) Natural selection on genes that under-lie human disease susceptibility. Curr Biol 18(12):883–889CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Kryukov GV, Pennacchio LA, Sunyaev SR (2007) Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet 80(4):727–739CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Charlesworth D (2006) Balancing selection and its effects on sequences in nearby genome regions. PLoS Genet 2(4):e64CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Andrés AM, Hubisz MJ, Indap A, Torgerson DG, Degenhardt JD, Boyko AR, Gutenkunst RN, White TJ, Green ED, Bustamante CD, Clark AG, Nielsen R (2009) Targets of balancing selection in the human genome. Mol Biol Evol 26(12):2755–2764CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Thakkinstian A, McKay GJ, McEvoy M, Chakravarthy U, Chakrabarti S, Silvestri G, Kaur I, Li X, Attia J (2011) Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 173(12):1365–1379CrossRefPubMedGoogle Scholar
  29. 29.
    Thiel S, Frederiksen PD, Jensenius JC (2006) Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 43(1–2):86–96CrossRefPubMedGoogle Scholar
  30. 30.
    Roy S, Knox K, Segal S, Griffiths D, Moore CE, Welsh KI, Smarason A, Day NP, McPheat WL, Crook DW, Hill AV (2002) MBL genotype and risk of invasive pneumococcal disease: a case–control study. Lancet 359(9317):1569–1573CrossRefPubMedGoogle Scholar
  31. 31.
    Moens L, Van Hoeyveld E, Peetermans WE, De Boeck C, Verhaegen J, Bossuyt X (2006) Mannose-binding lectin genotype and invasive pneumococcal infection. Hum Immunol 67(8):605–611CrossRefPubMedGoogle Scholar
  32. 32.
    Kronborg G, Garred P (2002) Mannose-binding lectin genotype as a risk factor for invasive pneumococcal infection. Lancet 360(9340):1176CrossRefPubMedGoogle Scholar
  33. 33.
    Søborg C, Madsen HO, Andersen AB, Lillebaek T, Kok-Jensen A, Garred P (2003) Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis 188(5):777–782CrossRefPubMedGoogle Scholar
  34. 34.
    Fitness J, Floyd S, Warndorff DK, Sichali L, Malema S, Crampin AC, Fine PE, Hill AV (2004) Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 71(3):341–349PubMedGoogle Scholar
  35. 35.
    Dornelles LN, Pereira-Ferrari L, Messias-Reason I (2006) Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms. Clin Exp Immunol 145(3):463–468CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Gigante PR, Kotchetkov IS, Kellner CP, Haque R, Ducruet AF, Hwang BY, Solomon RA, Heyer EJ, Connolly ES (2011) Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy. J Neurol Neurosurg Psychiatry 82(3):247–253CrossRefPubMedGoogle Scholar
  37. 37.
    Bryant EF (2001) The quest for the origins of Vedic culture: the Indo-Aryan migration debate. Oxford University Press, Oxford, ISBN 0-19-513777-9Google Scholar
  38. 38.
    Farjadian S, Ghaderi A (2007) HLA class II similarities in Iranian Kurds and Azeris. Int J Immunogenet 34(6):457–463CrossRefPubMedGoogle Scholar
  39. 39.
    Azarpira N, Namazi S, Khalili A, Tabesh M (2011) The investigation of allele and genotype frequencies of CYP3A5 (1/3) and P2Y12 (T744C) in Iran. Mol Biol Rep 38(8):4873–4877CrossRefPubMedGoogle Scholar
  40. 40.
    Azarpira N, Namazi S, Hendijani F, Banan M, Darai M (2010) Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran. Pharmacol Rep 62(4):740–746CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Najmeh Bazyar
    • 1
  • Negar Azarpira
    • 2
  • Saied Reza Khatami
    • 1
  • Hamid Galehdari
    • 1
  1. 1.Department of Genetics, Faculty of ScienceShahid Chamran University of AhwazAhvazIran
  2. 2.Transplant Research CenterShiraz University of Medical SciencesShirazIran

Personalised recommendations